Abstract
Severe acute respiratory syndrome coronavirus 2 (SARS-COV-2) resulted in the COVID-19 pandemic associated with severe morbidity, high mortality and adverse socioeconomic consequences across the world. Besides the development of effective vaccines for protecting individuals that are at higher risk, different therapeutic modalities have been continuously explored for the treatment of diseased persons to minimize the negative health and socioeconomic impacts of this highly fatal infection. Restricting the dissemination of SARS-COV-2 across the human population is a global challenge for health-care authorities. Therefore an array of experimental and clinical studies have been conducted to screen various natural, semi-synthetic and synthetic substances for prospective therapeutic potential against SARS-COV-2 infection. Based upon its causal role in the entrance of SARS-COV-2 into the host cells, ACE-2 has become the focus of drug development against COVID-19 infection. Accordingly, the inhibition of ACE-2 and viral S protein binding using bioactive natural products offers an efficient treatment strategy for COVID-19 infection. Although a wide range of natural products including alkaloids, flavonoids, phenols and terpenoids has been linked with ACE-2 blockage using in vitro and in silico studies, the effectiveness and safety of natural bioactive substances have not been validated. Therefore, natural compounds with potential ACE-2 inhibitory activity require detailed pharmacokinetic and safety evaluation through controlled clinical studies. This chapter discusses the various screening techniques and major ACE-2 inhibitory bioactive natural products in the context of SARS-CoV-2 infection.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Abd Allah ES, Gomaa AM (2015) Effects of curcumin and captopril on the functions of kidney and nerve in streptozotocin-induced diabetic rats: role of angiotensin converting enzyme 1. Appl Physiol Nutr Metab 40(10):1061–1067
Abubakar MB, Usman D, El-Saber Batiha G, Cruz-Martins N, Malami I, Ibrahim KG, Abubakar B, Bello MB, Muhammad A, Gan SH (2021) Natural products modulating angiotensin converting enzyme 2 (ACE2) as potential COVID-19 therapies. Front Pharmacol 12:629935
Adefegha SA, Oyeleye SI, Dada FA, Olasehinde TA, Oboh G (2018) Modulatory effect of quercetin and its glycosylated form on key enzymes and antioxidant status in rats penile tissue of paroxetine-induced erectile dysfunction. Biomed Pharmacother 107:1473–1479
Agunloye OM, Oboh G, Ademiluyi AO, Ademosun AO, Akindahunsi AA, Oyagbemi AA, Omobowale TO, Ajibade TO, Adedapo AA (2019) Cardio-protective and antioxidant properties of caffeic acid and chlorogenic acid: mechanistic role of angiotensin converting enzyme, cholinesterase and arginase activities in cyclosporine induced hypertensive rats. Biomed Pharmacother 109:450–458
Al Shukor N, Van Camp J, Gonzales GB, Staljanssens D, Struijs K, Zotti MJ, Raes K, Smagghe G (2013) Angiotensin-converting enzyme inhibitory effects by plant phenolic compounds: a study of structure activity relationships. J Agric Food Chem 61(48):11832–11839
Balmeh N, Mahmoudi S, Mohammadi N, Karabedianhajiabadi A (2020) Predicted therapeutic targets for COVID-19 disease by inhibiting SARS-CoV-2 and its related receptors. Inform Med Unlock 20:100407
Batlle D, Wysocki J, Satchell K (2020) Soluble angiotensin-converting enzyme 2: a potential approach for coronavirus infection therapy? Clin Sci 134(5):543–545
Beigi F, Lundahl P (1999) Immobilized biomembrane chromatography of highly lipophilic drugs. J Chromatogr A 852(1):313–317
Bernardi S, Michelli A, Zuolo G, Candido R, Fabris B (2016) Update on RAAS modulation for the treatment of diabetic cardiovascular disease. J Diabetes Res 2016:8917578
Beutler JA (2009) Natural products as a foundation for drug discovery. Curr Protoc Pharmacol 46(1):9.11.11–19.11.21
Chang H, Chang C-Y, Lee H-J, Chou C-Y, Chou T-C (2018) Magnolol ameliorates pneumonectomy and monocrotaline-induced pulmonary arterial hypertension in rats through inhibition of angiotensin II and endothelin-1 expression. Phytomedicine 51:205–213
Chen H, Du Q (2020) Potential natural compounds for preventing 2019-nCoV infection. Europe PMC
Chen C, Yang F-Q, Zuo H-L, Song Y-L, Xia Z-N, Xiao W (2013) Applications of biochromatography in the screening of bioactive natural products. J Chromatogr Sci 51(8):780–790
Chen X, Wu Y, Chen C, Gu Y, Zhu C, Wang S, Chen J, Zhang L, Lv L, Zhang G (2021) Identifying potential anti-COVID-19 pharmacological components of traditional Chinese medicine Lianhuaqingwen capsule based on human exposure and ACE2 biochromatography screening. Acta Pharm Sin B 11(1):222–236
Chiou S-Y, Sung J-M, Huang P-W, Lin S-D (2017) Antioxidant, antidiabetic, and antihypertensive properties of Echinacea purpurea flower extract and caffeic acid derivatives using in vitro models. J Med Food 20(2):171–179
Dai J, Mumper RJ (2010) Plant phenolics: extraction, analysis and their antioxidant and anticancer properties. Molecules 15(10):7313–7352
de Matos PH, da Silva TP, Mansano AB, Gancedo NC, Tonin FS, Pelloso FC, Petruco MV, de Melo EB, Fernandez-Llimos F, Sanches ACC, de Mello JCP, Chierrito D, de Medeiros Araújo DC (2022) Bioactive compounds as potential angiotensin-converting enzyme II inhibitors against COVID-19: a scoping review. Inflamm Res 71(12):1489–1500
De Vivo M, Masetti M, Bottegoni G, Cavalli A (2016) Role of molecular dynamics and related methods in drug discovery. J Med Chem 59(9):4035–4061
Deng Y, Aluko R, Jin Q, Zhang Y, Yuan L (2012) Inhibitory activities of baicalin against renin and angiotensin-converting enzyme. Pharm Biol 50(4):401–406
Dhawan M, Priyanka, Choudhary OP (2022) Omicron SARS-CoV-2 variant: reasons of emergence and lessons learnt. Int J Surg 97:106198
Elfiky AA (2021) Natural products may interfere with SARS-CoV-2 attachment to the host cell. J Biomol Struct Dyn 39(9):3194–3203
Ferrario CM, Mullick AE (2017) Renin angiotensin aldosterone inhibition in the treatment of cardiovascular disease. Pharmacol Res 125:57–71
Friesner RA, Banks JL, Murphy RB, Halgren TA, Klicic JJ, Mainz DT, Repasky MP, Knoll EH, Shelley M, Perry JK (2004) Glide: a new approach for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracy. J Med Chem 47(7):1739–1749
Gao Y, Wang Z, Zhang Y, Liu Y, Wang S, Sun W, Guo J, Yu C, Wang Y, Kong W (2018) Naringenin inhibits NG-nitro-L-arginine methyl ester-induced hypertensive left ventricular hypertrophy by decreasing angiotensin-converting enzyme 1 expression. Exp Ther Med 16(2):867–873
Gao J, Ding Y, Wang Y, Liang P, Zhang L, Liu R (2021) Oroxylin A is a severe acute respiratory syndrome coronavirus 2-spiked pseudotyped virus blocker obtained from Radix Scutellariae using angiotensin-converting enzyme II/cell membrane chromatography. Phytother Res 35(6):3194–3204
Geng F, Yang L, Chou G, Wang Z (2010) Bioguided isolation of angiotensin-converting enzyme inhibitors from the seeds of Plantago asiatica L. Phytother Res 24(7):1088–1094
Gheblawi M, Wang K, Viveiros A, Nguyen Q, Zhong J-C, Turner AJ, Raizada MK, Grant MB, Oudit GY (2020) Angiotensin-converting enzyme 2: SARS-CoV-2 receptor and regulator of the renin-angiotensin system: celebrating the 20th anniversary of the discovery of ACE2. Circ Res 126(10):1456–1474
Gimeno A, Ojeda-Montes MJ, Tomás-Hernández S, Cereto-Massagué A, Beltrán-Debón R, Mulero M, Pujadas G, Garcia-Vallvé S (2019) The light and dark sides of virtual screening: what is there to know? Int J Mol Sci 20(6):1375
Goyal B, Goyal D (2020) Targeting the dimerization of the main protease of coronaviruses: a potential broad-spectrum therapeutic strategy. ACS Comb Sci 22(6):297–305
Guerrero L, Castillo J, Quinones M, Garcia-Vallve S, Arola L, Pujadas G, Muguerza B (2012) Inhibition of angiotensin-converting enzyme activity by flavonoids: structure-activity relationship studies. PLoS One 7(11):e49493
Gutiérrez-Román AS, Gonzalez-Cortazar M, Trejo-Tapia G, Herrera-Ruiz M, Zamilpa A, Sanchéz-Mendoza E, De la Cruz-Sanchez NG, Jiménez-Ferrer E (2021) Angiotensin-converting enzyme inhibitors from Salvia elegans Vahl. Nat Prod Res 35(23):5344–5349
Gyebi GA, Adegunloye AP, Ibrahim IM, Ogunyemi OM, Afolabi SO, Ogunro OB (2022) Prevention of SARS-CoV-2 cell entry: insight from in silico interaction of drug-like alkaloids with spike glycoprotein, human ACE2, and TMPRSS2. J Biomol Struct Dyn 40(5):2121–2145
Haga J, Ichikawa K (2016) Virtual screening techniques and current computational infrastructures. Curr Pharm Des 22(23):3576–3584
Hamden K, Bengara A, Amri Z, Elfeki A (2013) Experimental diabetes treated with trigonelline: effect on key enzymes related to diabetes and hypertension, β-cell and liver function. Mol Cell Biochem 381(1):85–94
He L, Wang S, Geng X (2001) Coating and fusing cell membranes onto a silica surface and their chromatographic characteristics. Chromatographia 54(1):71–76
Hirayama N (2017) Docking simulations between drugs and HLA molecules associated with idiosyncratic drug toxicity. Drug Metab Pharmacokinet 32(1):31–39
Hoffmann M, Kleine-Weber H, Schroeder S, Krüger N, Herrler T, Erichsen S, Schiergens TS, Herrler G, Wu N-H, Nitsche A, Müller MA, Drosten C, Pöhlmann S (2020) SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell 181(2):271–280.e278
Hou X, Zhou M, Jiang Q, Wang S, He L (2009) A vascular smooth muscle/cell membrane chromatography–offline-gas chromatography/mass spectrometry method for recognition, separation and identification of active components from traditional Chinese medicines. J Chromatogr A 1216(42):7081–7087
Hu S, Wang J, Zhang Y, Bai H, Wang C, Wang N, He L (2021) Three salvianolic acids inhibit 2019-nCoV spike pseudovirus viropexis by binding to both its RBD and receptor ACE2. J Med Virol 93(5):3143–3151
Huang XY, Chen CX (2013) Effect of oxymatrine, the active component from radix Sophorae flavescentis (Kushen), on ventricular remodeling in spontaneously hypertensive rats. Phytomedicine 20(3–4):202–212
Huang S-Y, Zou X (2010) Advances and challenges in protein-ligand docking. Int J Mol Sci 11(8):3016–3034
Huo J, Miao Y, Zeng Y (2007) Gene chip technology and its application. Let Biotech 2:329–332
Islam R, Parves MR, Paul AS, Uddin N, Rahman MS, Mamun AA, Hossain MN, Ali MA, Halim MA (2021) A molecular modeling approach to identify effective antiviral phytochemicals against the main protease of SARS-CoV-2. J Biomol Struct Dyn 39(9):3213–3224
Jaeger R, Cuny E (2016) Terpenoids with special pharmacological significance: a review. Nat Prod Commun 11(9):1934578X1601100946
Junior AG, Tolouei SEL, Dos Reis Lívero FA, Gasparotto F, Boeing T, de Souza P (2021) Natural agents modulating ACE-2: a review of compounds with potential against SARS-CoV-2 infections. Curr Pharm Des 27(13):1588–1596
Kadakol A, Malek V, Goru SK, Pandey A, Bagal S, Gaikwad AB (2015) Esculetin attenuates alterations in Ang II and acetylcholine mediated vascular reactivity associated with hyperinsulinemia and hyperglycemia. Biochem Biophys Res Commun 461(2):342–347
Kai H, Kai M (2020) Interactions of coronaviruses with ACE2, angiotensin II, and RAS inhibitors—lessons from available evidence and insights into COVID-19. Hypertens Res 43(7):648–654
Kang DG, Sohn EJ, Kwon EK, Han JH, Oh H, Lee HS (2002) Effects of berberine on angiotensin-converting enzyme and NO/cGMP system in vessels. Vasc Pharmacol 39(6):281–286
Kanmodi KK, Kanmodi PA (2020) COVID-19 stigmatization: a devil and a deep blue sea. Populat Med 2:10. https://doi.org/10.18332/popmed/121098
Ke Z, Su Z, Zhang X, Cao Z, Ding Y, Cao L, Ding G, Wang Z, Liu H, Xiao W (2017) Discovery of a potent angiotensin converting enzyme inhibitor via virtual screening. Bioorg Med Chem Lett 27(16):3688–3692
Khan S, Siddique R, Shereen MA, Ali A, Liu J, Bai Q, Bashir N, Xue M (2020) Emergence of a novel coronavirus, severe acute respiratory syndrome coronavirus 2: biology and therapeutic options. J Clin Microbiol 58(5):e00187–e00120
Kim EN, Kim MY, Lim JH, Kim Y, Shin SJ, Park CW, Kim Y-S, Chang YS, Yoon HE, Choi BS (2018) The protective effect of resveratrol on vascular aging by modulation of the renin–angiotensin system. Atherosclerosis 270:123–131
Kiss A, Kowalski J, Melzig MF (2004) Compounds from Epilobium angustifolium inhibit the specific metallopeptidases ACE, NEP and APN. Planta Med 70(10):919–923
Kuhn JH, Li W, Choe H, Farzan M (2004) Angiotensin-converting enzyme 2: a functional receptor for SARS coronavirus. Cell Mol Life Sci 61(21):2738–2743
Kumar A, Choudhir G, Shukla SK, Sharma M, Tyagi P, Bhushan A, Rathore M (2021) Identification of phytochemical inhibitors against main protease of COVID-19 using molecular modeling approaches. J Biomol Struct Dyn 39(10):3760–3770
Lagerquist C, Beigi F, Karlén A, Lennernäs H, Lundahl P (2001) Effects of cholesterol and model transmembrane proteins on drug partitioning into lipid bilayers as analysed by immobilized-liposome chromatography. J Pharm Pharmacol 53(11):1477–1487
Lee J-W, Baek N-I, Lee D-Y (2015) Inhibitory effects of seco-triterpenoids from Acanthopanax sessiliflorus fruits on HUVEC invasion and ACE activity. Nat Prod Commun 10(9):1934578X1501000907
Letko M, Marzi A, Munster V (2020) Functional assessment of cell entry and receptor usage for SARS-CoV-2 and other lineage B betacoronaviruses. Nat Microbiol 5(4):562–569
Li G-B, Yang L-L, Wang W-J, Li L-L, Yang S-Y (2013) ID-score: a new empirical scoring function based on a comprehensive set of descriptors related to protein–ligand interactions. J Chem Inf Model 53(3):592–600
Lionta E, Spyrou G, Vassilatis DK, Cournia Z (2014) Structure-based virtual screening for drug discovery: principles, applications and recent advances. Curr Top Med Chem 14(16):1923–1938
Liu Q, Tian J, Xu Y, Li C, Meng X, Fu F (2016) Protective effect of RA on myocardial infarction-induced cardiac fibrosis via AT1R/p38 MAPK pathway signaling and modulation of the ACE2/ACE ratio. J Agric Food Chem 64(35):6716–6722
Liu H, Jiang Y, Li M, Yu X, Sui D, Fu L (2019) Ginsenoside Rg3 attenuates angiotensin II-mediated renal injury in rats and mice by upregulating angiotensin-converting enzyme 2 in the renal tissue. Evid Based Complement Alternat Med 2019:1–11
Lu R, Zhao X, Li J, Niu P, Yang B, Wu H, Wang W, Song H, Huang B, Zhu N (2020) Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. Lancet 395(10224):565–574
Luo J, Zhang C, Liu Q, Ou S, Zhang L, Peng X (2017) Combinative effect of sardine peptides and quercetin alleviates hypertension through inhibition of angiotensin I converting enzyme activity and inflammation. Food Res Int 100:579–585
Lv Y, Wang S, Liang P, Wang Y, Zhang X, Jia Q, Fu J, Han S, He L (2021) Screening and evaluation of anti-SARS-CoV-2 components from Ephedra sinica by ACE2/CMC-HPLC-IT-TOF-MS approach. Anal Bioanal Chem 413(11):2995–3004
Ma L, Liu H, Liu X, Yuan X, Xu C, Wang F, Lin J, Xu R, Zhang D (2021) Screening S protein-ACE2 blockers from natural products: strategies and advances in the discovery of potential inhibitors of COVID-19. Eur J Med Chem 226:113857–113857
Malviya S, Parihar A, Parihar DS, Khan R (2022) Natural products as a therapy to combat against SARS-CoV-2 virus infection. In: Parihar A, Khan R, Kumar A, Kaushik AK, Gohel H (eds) Computational approaches for novel therapeutic and diagnostic designing to mitigate SARS-CoV-2 infection. Academic Press, pp 115–145
Maurya VK, Kumar S, Prasad AK, Bhatt ML, Saxena SK (2020) Structure-based drug designing for potential antiviral activity of selected natural products from Ayurveda against SARS-CoV-2 spike glycoprotein and its cellular receptor. Virus 31(2):179–193
Moran CS, Biros E, Krishna SM, Wang Y, Tikellis C, Morton SK, Moxon JV, Cooper ME, Norman PE, Burrell LM (2017) Resveratrol inhibits growth of experimental abdominal aortic aneurysm associated with upregulation of angiotensin-converting enzyme 2. Arterioscler Thromb Vasc Biol 37(11):2195–2203
Muchtaridi M, Fauzi M, Khairul Ikram NK, Mohd Gazzali A, Wahab HA (2020) Natural flavonoids as potential angiotensin-converting enzyme 2 inhibitors for anti-SARS-CoV-2. Molecules 25(17):3980
Muhammad SA, Fatima N (2015) In silico analysis and molecular docking studies of potential angiotensin-converting enzyme inhibitor using quercetin glycosides. Pharmacogn Mag 11(42):123
Ngwa W, Kumar R, Thompson D, Lyerly W, Moore R, Reid T-E, Lowe H, Toyang N (2020) Potential of flavonoid-inspired Phytomedicines against COVID-19. Molecules 25(11):2707
Oakes JM, Fuchs RM, Gardner JD, Lazartigues E, Yue X (2018) Nicotine and the renin-angiotensin system. Am J Phys Regul Integr Comp Phys 315(5):R895–R906
Ojeda D, Jiménez-Ferrer E, Zamilpa A, Herrera-Arellano A, Tortoriello J, Alvarez L (2010) Inhibition of angiotensin converting enzyme (ACE) activity by the anthocyanins delphinidin-and cyanidin-3-O-sambubiosides from Hibiscus sabdariffa. J Ethnopharmacol 127(1):7–10
Okimoto N, Futatsugi N, Fuji H, Suenaga A, Morimoto G, Yanai R, Ohno Y, Narumi T, Taiji M (2009) High-performance drug discovery: computational screening by combining docking and molecular dynamics simulations. PLoS Comput Biol 5(10):e1000528
Patching SG (2014) Surface plasmon resonance spectroscopy for characterisation of membrane protein–ligand interactions and its potential for drug discovery. Biochim BiophysActa (BBA) Biomemb 1838(1):43–55
Prabowo BA, Purwidyantri A, Liu K-C (2018) Surface plasmon resonance optical sensor: a review on light source technology. Biosensors 8(3):80
Rakib A, Paul A, Chy MNU, Sami SA, Baral SK, Majumder M, Tareq AM, Amin MN, Shahriar A, Uddin MZ, Dutta M, Tallei TE, Emran TB, Simal-Gandara J (2020) Biochemical and computational approach of selected phytocompounds from Tinospora crispa in the management of COVID-19. Molecules 25(17):3936
Raman K, Rajagopal K, Islam F, Dhawan M, Mitra S, Aparna B, Varakumar P, Byran G, Choudhary OP, Emran TB (2022) Role of natural products towards the SARS-CoV-2: a critical review. Ann Med Surg (Lond) 80:104062
Sanchis-Gomar F, Lavie CJ, Perez-Quilis C, Henry BM, Lippi G (2020) Angiotensin-converting enzyme 2 and antihypertensives (angiotensin receptor blockers and angiotensin-converting enzyme inhibitors) in coronavirus disease 2019. Mayo Clin Proc 95(6):1222–1230
Scherf U, Ross DT, Waltham M, Smith LH, Lee JK, Tanabe L, Kohn KW, Reinhold WC, Myers TG, Andrews DT (2000) A gene expression database for the molecular pharmacology of cancer. Nat Genet 24(3):236–244
Simões e Silva AC, Teixeira MM (2016) ACE inhibition, ACE2 and angiotensin-(1-7) axis in kidney and cardiac inflammation and fibrosis. Pharmacol Res 107:154–162
Smith M, Smith JC (2020) Repurposing therapeutics for COVID-19: supercomputer-based docking to the SARS-CoV-2 viral spike protein and viral spike protein-human ACE2 interface
Sui H, Yu Q, Zhi Y, Geng G, Liu H, Xu H (2010) Effects of apigenin on the expression of angiotensin-converting enzyme 2 in kidney in spontaneously hypertensive rats. J Hygiene Res 39(6):693–696, 700
Tiao M-M, Lin Y-J, Yu H-R, Sheen J-M, Lin I, Lai Y-J, Tain Y-L, Huang L-T, Tsai C-C (2018) Resveratrol ameliorates maternal and post-weaning high-fat diet-induced nonalcoholic fatty liver disease via renin-angiotensin system. Lipids Health Dis 17(1):1–11
Tikellis C, Thomas MC (2012) Angiotensin-converting enzyme 2 (ACE2) is a key modulator of the renin angiotensin system in health and disease. Int J Pept 2012:256294
To K, Tong JH, Chan PK, Au FW, Chim SS, Allen Chan K, Cheung JL, Liu EY, Tse GM, Lo AW (2004) Tissue and cellular tropism of the coronavirus associated with severe acute respiratory syndrome: an in-situ hybridization study of fatal cases. J Pathol 202(2):157–163
Tutunchi H, Naeini F, Ostadrahimi A, Hosseinzadeh-Attar MJ (2020) Naringenin, a flavanone with antiviral and anti-inflammatory effects: a promising treatment strategy against COVID-19. Phytother Res 34(12):3137–3147
Utomo RY, Ikawati M, Meiyanto E (2020) Revealing the potency of citrus and galangal constituents to halt SARS-CoV-2 infection
Vardhan S, Sahoo SK (2020) In silico ADMET and molecular docking study on searching potential inhibitors from limonoids and triterpenoids for COVID-19. Comput Biol Med 124:103936
Verdecchia P, Cavallini C, Spanevello A, Angeli F (2020) The pivotal link between ACE2 deficiency and SARS-CoV-2 infection. Eur J Intern Med 76:14–20
Wang H, Zou H, Kong L, Ni J (2000) Analysis of bioactive components in traditional Chinese medicines by molecular biochromatography with α1-acid glycoprotein stationary phase. J Basic Clin Physiol Pharmacol 11(2):155–172
Wang XW, Gao HJ, Fang DC (2008) Advances in gene chip technique in Barrett’s metaplasia and adenocarcinoma. J Dig Dis 9(2):68–71
Wang Z, Wang S, Zhao J, Yu C, Hu Y, Tu Y, Yang Z, Zheng J, Wang Y, Gao Y (2019) Naringenin ameliorates renovascular hypertensive renal damage by normalizing the balance of renin-angiotensin system components in rats. Int J Med Sci 16(5):644
Wang Z, Sun H, Shen C, Hu X, Gao J, Li D, Cao D, Hou T (2020) Combined strategies in structure-based virtual screening. Phys Chem Chem Phys 22(6):3149–3159
Wei X, Zhu X, Hu N, Zhang X, Sun T, Xu J, Bian X (2015) Baicalin attenuates angiotensin II-induced endothelial dysfunction. Biochem Biophys Res Commun 465(1):101–107
Wu H, Li Y, Wang Y, Xu D, Li C, Liu M, Sun X, Li Z (2014) Tanshinone IIA attenuates bleomycin-induced pulmonary fibrosis via modulating angiotensin-converting enzyme 2/angiotensin-(1-7) axis in rats. Int J Med Sci 11(6):578
Wu C, Liu Y, Yang Y, Zhang P, Zhong W, Wang Y, Wang Q, Xu Y, Li M, Li X (2020) Analysis of therapeutic targets for SARS-CoV-2 and discovery of potential drugs by computational methods. Acta Pharm Sin B 10(5):766–788
Wunpathe C, Potue P, Maneesai P, Bunbupha S, Prachaney P, Kukongviriyapan U, Kukongviriyapan V, Pakdeechote P (2018) Hesperidin suppresses renin-angiotensin system mediated NOX2 over-expression and sympathoexcitation in 2K-1C hypertensive rats. Am J Chin Med 46(04):751–767
Wysocki J, Ye M, Rodriguez E, González-Pacheco FR, Barrios C, Evora K, Schuster M, Loibner H, Brosnihan KB, Ferrario CM (2010) Targeting the degradation of angiotensin II with recombinant angiotensin-converting enzyme 2: prevention of angiotensin II–dependent hypertension. Hypertension 55(1):90–98
Yan R, Zhang Y, Li Y, Xia L, Guo Y, Zhou Q (2020) Structural basis for the recognition of SARS-CoV-2 by full-length human ACE2. Science 367(6485):1444–1448
Yeung ML, Teng JLL, Jia L, Zhang C, Huang C, Cai J-P, Zhou R, Chan K-H, Zhao H, Zhu L (2021) Soluble ACE2-mediated cell entry of SARS-CoV-2 via interaction with proteins related to the renin-angiotensin system. Cell 184(8):2212–2228. e2212
Yoo MJ, Smith QR, Hage DS (2009) Studies of imipramine binding to human serum albumin by high-performance affinity chromatography. J Chromatogr B 877(11–12):1149–1154
Zhao H-Y, Jiang J-G (2010) Application of chromatography technology in the separation of active components from nature derived drugs. Mini Rev Med Chem 10(13):1223–1234
Zheng X, Wang S, Zou X, Jing Y, Yang R, Li S, Wang F (2017) Ginsenoside Rb1 improves cardiac function and remodeling in heart failure. Exp Anim 66(3):217–228
Zhou P, Yang X-L, Wang X-G, Hu B, Zhang L, Zhang W, Si H-R, Zhu Y, Li B, Huang C-L, Chen H-D, Chen J, Luo Y, Guo H, Jiang R-D, Liu M-Q, Chen Y, Shen X-R, Wang X, Zheng X-S, Zhao K, Chen Q-J, Deng F, Liu L-L, Yan B, Zhan F-X, Wang Y-Y, Xiao G-F, Shi Z-L (2020) A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature 579(7798):270–273
Zhu T (2003) Global analysis of gene expression using GeneChip microarrays. Curr Opin Plant Biol 6(5):418–425
Zi C, Zhang N, Yang L, Wang L, Wu Y, Su Y, Wang X (2020) Discovery of a potent angiotensin converting enzyme 2 inhibitor from Chinese Medicinal and Edible Plant via Docking-based Virtual Screening. Bioorg Med Chem Lett
Author information
Authors and Affiliations
Corresponding authors
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2023 The Author(s), under exclusive license to Springer Nature Singapore Pte Ltd.
About this chapter
Cite this chapter
Adil, M., Tiwari, P., Chen, JT., Kanwal, S. (2023). Plant-Derived Bioactive Compounds as Potential ACE-2 Inhibitors Against SARS-CoV-2 Infection. In: Chen, JT. (eds) Ethnopharmacology and Drug Discovery for COVID-19: Anti-SARS-CoV-2 Agents from Herbal Medicines and Natural Products. Springer, Singapore. https://doi.org/10.1007/978-981-99-3664-9_8
Download citation
DOI: https://doi.org/10.1007/978-981-99-3664-9_8
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-99-3663-2
Online ISBN: 978-981-99-3664-9
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)